Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 1249 results for "sun pharma"

Sun Pharma inks licensing pact with US-based Merck for tildrakizumab
Business Standard

Sun Pharma inks licensing pact with US-based Merck for tildrak...

Indian firm will acquire worldwide rights to tildrakizumab for use in all human indications from Merck in exchange for an upfront payment of $ 80 million BS B2B Bureau | Mumbai September 19, 2014 Last Updated at 17:26 IST Sun Pharmaceutical Industries Ltd and ... Business Standard, 20 hours ago
USFDA continues to audit Sun Pharma's Halol plant Money Control, 20 hours ago
[x]  

134 images for sun pharma

Money Today, 1 day ago
Financial Express, 6 hours ago
Sify, 2 days ago
NDTV Profit, 3 days ago
Financial Express, 3 days ago
Sify, 4 days ago
NDTV, 5 days ago
India TV, 1 week ago
NDTV, 5 days ago
Sify, 5 days ago

Buy Sun Pharma with a target of Rs 849: Sandeep Wagle

In a chat with ET Now, Sandeep Wagle, Founder & CEO, Power My Wealth, shares his views on Sun Pharma. ET Now: What is your call on Sun Pharma? Sandeep Wagle: Sun Pharma is a 'BUY' call with a target of Rs 849 and a stop loss of
 Economic Times23 hours ago Sell Sun Pharma Ltd with a target of Rs 795: Mitesh Thacker  Economic Times1 week ago Sell Sun Pharma with a target of Rs 795: Sandeep Wagle  Economic Times1 week ago Buy Sun Pharma; target of Rs 980: Motilal Oswal  Money Control1 week ago
[x]  

Indian pharma could gain from China-India MoUs

MoUs aimed at facilitating market access, cooperation on drug regulations could increase inroads into China pharma market Pharmaceutical products from India could gain easier entry into the China market, thanks to two of the many MoUs signed ...
 Express Pharma19 hours ago Xi opens doors for Indian firms  The Financial Chronicle1 day ago

Hold Sun Pharma; may test Rs 855-860: Akshata Deshmukh

Akshata Deshmukh of Networth Stock Broking is of the view that one may hold Sun Pharmaceutical Industries.
 Money Control23 hours ago

Remain bullish on pharma sector: Deven Choksey

In a chat with ET Now, Deven Choksey, MD, , shares his views on the pharma sector. ET Now: How do you react to all the news flow there has been in the pharmaceutical space? What are the ideas that you are propagating there, especially the likes of ...
 Economic Times1 day ago Accumulate Sun Pharma, says Deven Choksey  Money Control1 week ago See growth opportunities in pharma sector: Kunj Bansal  Economic Times1 week ago
Money Control

Nifty struggles below 8150; IT pharma lead

Defensive buying is seen in IT and pharma stocks. TCS, Cipla, Sun Pharma. Infosys and Wipro are top gainers in the Sensex while LT, HUL, SBI and Axis Bank are major laggards.
 Money Control1 day ago Sensex breaks 27,000; Sun Pharma, Coal India top losers  Business Standard1 week ago Sensex falls below 27K on profit-taking, weak Asian cues; realty stocks tumble  MSN India2 weeks ago Nifty starts Sept series at record high; Maruti up 3%  Money Control2 weeks ago
[x]  
Business Today India

Sun Pharma stock ends 2% higher

 India Infoline1 day ago Sensex jumps 145 points in early trade; Tata Steel, Sun Pharma rally  MyIris1 week ago Sensex gains 50 points in early trade; Hindalco, Sun Pharma lead  Myiris1 month ago Sensex falls 71 points in early trade; Infosys, Axis Bank drag  MyIris2 days ago
[x]  

Nifty hovers around 8,130 aided by gains in IT, pharma

Markets continue to remain choppy in early noon deals, even as the benchmark indices recovered from day lows. The gains were aided by IT and pharma names. At 1250 hrs, the Sensex was up 40 points at 27,151 and the Nifty gained 19 points to trade at ...
 Business Standard India1 day ago

Sun Pharma shares end nearly 2 pc up on Merck licensing pact

Shares of Sun Pharmaceutical Industries today ended nearly 2 per cent higher after the company entered into a licensing agreement with Merck & Co Inc for using investigational therapeutic antibody candidate, tildrakizumab for treatment of plaque psoriasis.
 Business Standard1 day ago Sun Pharma shares rally on licensing pact with Merck  Myiris2 days ago Sun Pharma shares end nearly 2% up on Merck licensing pact  Economic Times1 day ago Sun Pharmaceutica shares end nearly 2 per cent up on Merck & Co Inc licensing pact  Economic Times1 day ago

Sun Pharma shares up 3% on Merck licensing pact

Shares of Sun Pharmaceutical Industries today rose nearly 3 per cent after the company entered into a licensing agreement with Merck & Co Inc for using investigational therapeutic antibody candidate, tildrakizumab, for the treatment of plaque ...
 Hindu Business Line2 days ago Sun Pharma shares gain nearly 3% on Merck licensing pact  Business Standard2 days ago Sun Pharma gains after inking pact with Merck  Business Standard2 days ago Sun Pharma in focus on inking pact with Merck  Capital Market2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less